Biotech

All Articles

Sanofi's $80M bank on Key dystrophy medicine ends in period 3 crash

.Just 4 months after Sanofi wager $80 million in upfront cash on Pivot Therapies' losmapimod, the pr...

Oncternal stock sinks 60% amid layoffs, trial discontinuations

.Cancer cells company Oncternal Rehabs is actually folding all its own medical tests as well as layi...

Roche is actually holding out chances that its own injectable weight problems prospect could at some point display 25% fat loss in late-stage test

.Roche is keeping out hopes that its own injectable being overweight possibility can eventually disp...

Novo Nordisk barrages 'remarkable' weight loss lead for dual-acting oral medicine in early trial

.Novo Nordisk has actually elevated the cover on a stage 1 test of its dental amylin as well as GLP-...

AbbVie sues BeiGene over blood stream cancer cells medication classified information

.Merely a few brief full weeks after gaining an FDA Fast Track tag for its own investigational BTK d...

Lilly supplies one-two strike along with second tranche of beneficial information on every week blood insulin applicant

.Not long after a beneficial records decline for Eli Lilly's efsitora alfa, the Indianapolis-based b...

BridgeBio reduces genetics treatment spending plan as scientific records let down

.BridgeBio Pharma is actually slashing its genetics treatment spending plan and drawing back from th...

GSK relinquishes HSV vaccination really hopes after period 2 neglect, transferring ethnicity to Moderna, BioNTech

.GSK's effort to cultivate the very first vaccine for genital herpes simplex infection (HSV) has act...

GSK's long-acting asthma medicine cut in half strikes in period 3

.GSK's long-acting bronchial asthma treatment has been presented to halve the amount of assaults in ...

AstraZeneca, Daiichi unbox Dato-DXd's general survival fall short

.AstraZeneca and also Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has actually sto...